Mid-term follow-up data after endoscopic lung volume reduction with nitinol coils in patients with very severe emphysema
| العنوان: | Mid-term follow-up data after endoscopic lung volume reduction with nitinol coils in patients with very severe emphysema |
|---|---|
| المؤلفون: | Hans Jost Achenbach, Mathias Jüch |
| المصدر: | 1.4 Interventional Pulmonology. |
| بيانات النشر: | European Respiratory Society, 2015. |
| سنة النشر: | 2015 |
| مصطلحات موضوعية: | Lung volume reduction, medicine.medical_specialty, COPD, business.industry, medicine.disease, Bronchoscopic lung volume reduction, respiratory tract diseases, Surgery, Mid term follow up, Quality of life, Medicine, In patient, business, Nuclear medicine, Adverse effect, Lung function |
| الوصف: | Background: Bilateral bronchoscopic lung volume reduction with nitinol coils (PneumRx Inc., USA) in severe emphysema has been shown to improve exercise capacity, lung function, and quality of life. We present mid-term follow-up (f/u) data from 30 bilaterally treated patients. Methods: 30 patients with COPD GOLD III/IV, category D and heterogenous or homogenous emphysema (mean RV 253±54%, mean FEV1 29,5±5,7%, mean 6MWD 299±108m, mean CAT 24,7±7 pts.) underwent bilateral coil treatment. F/u including lung function, exercise capacity, quality of life and adverse events was conducted at several points of time from 24 to 577 days post-treatment. Results: Mean f/u time so far was 241±148 days. Compared to baseline patients showed an improvement in all measured parameters (mean RV -491±853 ml, mean FEV1+31±204 ml, mean 6MWD +26±82m, mean CAT score -4,3±7 pts.). In about 10% of patients transient procedural discomforts (e.g. mild hemoptysis) occurred, usually within the first days following treatment and resolving spontaneously. Updated f/u data will be presented at the ERS congress. Conclusions: Our data confirm that coil treatment is a safe and effective add-on therapy for patients with severe COPD and emphysema. In accordance with larger studies we could demonstrate improvements in exercise capacity, lung function, and quality of life in mid-term f/u. RV reduction was statistically the most significant parameter, reflecting lung volume reduction via tissue re-tensioning concept of coil treatment. |
| DOI: | 10.1183/13993003.congress-2015.pa808 |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_________::497450d939685d060d766100aaa29edb https://doi.org/10.1183/13993003.congress-2015.pa808 |
| رقم الانضمام: | edsair.doi...........497450d939685d060d766100aaa29edb |
| قاعدة البيانات: | OpenAIRE |
| ResultId |
1 |
|---|---|
| Header |
edsair OpenAIRE edsair.doi...........497450d939685d060d766100aaa29edb 789 3 unknown 789.253845214844 |
| PLink |
https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........497450d939685d060d766100aaa29edb&custid=s6537998&authtype=sso |
| FullText |
Array
(
[Availability] => 0
)
Array ( [0] => Array ( [Url] => https://explore.openaire.eu/search/publication?articleId=doi_________::497450d939685d060d766100aaa29edb# [Name] => EDS - OpenAIRE [Category] => fullText [Text] => View record in OpenAIRE [MouseOverText] => View record in OpenAIRE ) ) |
| Items |
Array
(
[Name] => Title
[Label] => Title
[Group] => Ti
[Data] => Mid-term follow-up data after endoscopic lung volume reduction with nitinol coils in patients with very severe emphysema
)
Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => <searchLink fieldCode="AR" term="%22Hans+Jost+Achenbach%22">Hans Jost Achenbach</searchLink><br /><searchLink fieldCode="AR" term="%22Mathias+Jüch%22">Mathias Jüch</searchLink> ) Array ( [Name] => TitleSource [Label] => Source [Group] => Src [Data] => <i>1.4 Interventional Pulmonology</i>. ) Array ( [Name] => Publisher [Label] => Publisher Information [Group] => PubInfo [Data] => European Respiratory Society, 2015. ) Array ( [Name] => DatePubCY [Label] => Publication Year [Group] => Date [Data] => 2015 ) Array ( [Name] => Subject [Label] => Subject Terms [Group] => Su [Data] => <searchLink fieldCode="DE" term="%22Lung+volume+reduction%22">Lung volume reduction</searchLink><br /><searchLink fieldCode="DE" term="%22medicine%2Emedical%5Fspecialty%22">medicine.medical_specialty</searchLink><br /><searchLink fieldCode="DE" term="%22COPD%22">COPD</searchLink><br /><searchLink fieldCode="DE" term="%22business%2Eindustry%22">business.industry</searchLink><br /><searchLink fieldCode="DE" term="%22medicine%2Edisease%22">medicine.disease</searchLink><br /><searchLink fieldCode="DE" term="%22Bronchoscopic+lung+volume+reduction%22">Bronchoscopic lung volume reduction</searchLink><br /><searchLink fieldCode="DE" term="%22respiratory+tract+diseases%22">respiratory tract diseases</searchLink><br /><searchLink fieldCode="DE" term="%22Surgery%22">Surgery</searchLink><br /><searchLink fieldCode="DE" term="%22Mid+term+follow+up%22">Mid term follow up</searchLink><br /><searchLink fieldCode="DE" term="%22Quality+of+life%22">Quality of life</searchLink><br /><searchLink fieldCode="DE" term="%22Medicine%22">Medicine</searchLink><br /><searchLink fieldCode="DE" term="%22In+patient%22">In patient</searchLink><br /><searchLink fieldCode="DE" term="%22business%22">business</searchLink><br /><searchLink fieldCode="DE" term="%22Nuclear+medicine%22">Nuclear medicine</searchLink><br /><searchLink fieldCode="DE" term="%22Adverse+effect%22">Adverse effect</searchLink><br /><searchLink fieldCode="DE" term="%22Lung+function%22">Lung function</searchLink> ) Array ( [Name] => Abstract [Label] => Description [Group] => Ab [Data] => Background: Bilateral bronchoscopic lung volume reduction with nitinol coils (PneumRx Inc., USA) in severe emphysema has been shown to improve exercise capacity, lung function, and quality of life. We present mid-term follow-up (f/u) data from 30 bilaterally treated patients. Methods: 30 patients with COPD GOLD III/IV, category D and heterogenous or homogenous emphysema (mean RV 253±54%, mean FEV1 29,5±5,7%, mean 6MWD 299±108m, mean CAT 24,7±7 pts.) underwent bilateral coil treatment. F/u including lung function, exercise capacity, quality of life and adverse events was conducted at several points of time from 24 to 577 days post-treatment. Results: Mean f/u time so far was 241±148 days. Compared to baseline patients showed an improvement in all measured parameters (mean RV -491±853 ml, mean FEV1+31±204 ml, mean 6MWD +26±82m, mean CAT score -4,3±7 pts.). In about 10% of patients transient procedural discomforts (e.g. mild hemoptysis) occurred, usually within the first days following treatment and resolving spontaneously. Updated f/u data will be presented at the ERS congress. Conclusions: Our data confirm that coil treatment is a safe and effective add-on therapy for patients with severe COPD and emphysema. In accordance with larger studies we could demonstrate improvements in exercise capacity, lung function, and quality of life in mid-term f/u. RV reduction was statistically the most significant parameter, reflecting lung volume reduction via tissue re-tensioning concept of coil treatment. ) Array ( [Name] => DOI [Label] => DOI [Group] => ID [Data] => 10.1183/13993003.congress-2015.pa808 ) Array ( [Name] => URL [Label] => Access URL [Group] => URL [Data] => <link linkTarget="URL" linkTerm="https://explore.openaire.eu/search/publication?articleId=doi_________::497450d939685d060d766100aaa29edb" linkWindow="_blank">https://explore.openaire.eu/search/publication?articleId=doi_________::497450d939685d060d766100aaa29edb</link><br /><link linkTarget="URL" linkTerm="https://doi.org/10.1183/13993003.congress-2015.pa808" linkWindow="_blank">https://doi.org/10.1183/13993003.congress-2015.pa808</link> ) Array ( [Name] => AN [Label] => Accession Number [Group] => ID [Data] => edsair.doi...........497450d939685d060d766100aaa29edb ) |
| RecordInfo |
Array
(
[BibEntity] => Array
(
[Identifiers] => Array
(
[0] => Array
(
[Type] => doi
[Value] => 10.1183/13993003.congress-2015.pa808
)
)
[Languages] => Array
(
[0] => Array
(
[Text] => Undetermined
)
)
[Subjects] => Array
(
[0] => Array
(
[SubjectFull] => Lung volume reduction
[Type] => general
)
[1] => Array
(
[SubjectFull] => medicine.medical_specialty
[Type] => general
)
[2] => Array
(
[SubjectFull] => COPD
[Type] => general
)
[3] => Array
(
[SubjectFull] => business.industry
[Type] => general
)
[4] => Array
(
[SubjectFull] => medicine.disease
[Type] => general
)
[5] => Array
(
[SubjectFull] => Bronchoscopic lung volume reduction
[Type] => general
)
[6] => Array
(
[SubjectFull] => respiratory tract diseases
[Type] => general
)
[7] => Array
(
[SubjectFull] => Surgery
[Type] => general
)
[8] => Array
(
[SubjectFull] => Mid term follow up
[Type] => general
)
[9] => Array
(
[SubjectFull] => Quality of life
[Type] => general
)
[10] => Array
(
[SubjectFull] => Medicine
[Type] => general
)
[11] => Array
(
[SubjectFull] => In patient
[Type] => general
)
[12] => Array
(
[SubjectFull] => business
[Type] => general
)
[13] => Array
(
[SubjectFull] => Nuclear medicine
[Type] => general
)
[14] => Array
(
[SubjectFull] => Adverse effect
[Type] => general
)
[15] => Array
(
[SubjectFull] => Lung function
[Type] => general
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => Mid-term follow-up data after endoscopic lung volume reduction with nitinol coils in patients with very severe emphysema
[Type] => main
)
)
)
[BibRelationships] => Array
(
[HasContributorRelationships] => Array
(
[0] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Hans Jost Achenbach
)
)
)
[1] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Mathias Jüch
)
)
)
)
[IsPartOfRelationships] => Array
(
[0] => Array
(
[BibEntity] => Array
(
[Dates] => Array
(
[0] => Array
(
[D] => 01
[M] => 09
[Type] => published
[Y] => 2015
)
)
[Identifiers] => Array
(
[0] => Array
(
[Type] => issn-locals
[Value] => edsair
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => 1.4 Interventional Pulmonology
[Type] => main
)
)
)
)
)
)
)
|
| IllustrationInfo |